Akebia Therapeutics Inc (AKBA)

Nov 20, 2024

Q3 2024 Earnings: Hold Akebia Therapeutics (NASDAQ:AKBA) - Seeking Alpha

Nov 20, 2024

Nov 14, 2024

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease - Yahoo Finance UK

Nov 14, 2024

Nov 13, 2024

Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com - Defense World

Nov 13, 2024

Nov 12, 2024

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference - StockTitan

Nov 12, 2024

Nov 09, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 09, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Earnings call: Akebia reports Q3 results, gears up for Vafseo launch - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Price Is Right But Growth Is Lacking After Shares Rocket 41% - Simply Wall St

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics: Q3 Earnings Snapshot - CT Insider

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Prepares for Vafseo Launch - TipRanks

Nov 08, 2024

Nov 07, 2024

Akebia Therapeutics Inc. (AKBA) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - citybiz

Nov 07, 2024

Nov 07, 2024

Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

SEC Form 10-Q filed by Akebia Therapeutics Inc. - Quantisnow

Nov 07, 2024

Nov 06, 2024

Here's Why You Should Consider Buying Akebia (AKBA) Stock - MSN

Nov 06, 2024

Nov 04, 2024

Akebia Therapeutics to present at upcoming investor conferences - MSN

Nov 04, 2024

Nov 02, 2024

Akebia Therapeutics (AKBA) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 02, 2024

Nov 01, 2024

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Lelezard

Nov 01, 2024

Nov 01, 2024

Akebia Therapeutics Signs Commercial Supply Contract with Leadin - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights - citybiz

Nov 01, 2024

Oct 31, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Down 6.0% in October - Defense World

Oct 31, 2024

Oct 31, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Short Interest Update - MarketBeat

Oct 31, 2024

Oct 25, 2024

Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Reaffirmed by HC Wainwright - Defense World

Oct 25, 2024

Oct 23, 2024

Akebia stock climbs 8% on dialysis provider supply agreement - MSN

Oct 23, 2024

Oct 23, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 23, 2024

Oct 23, 2024

Akebia Therapeutics (NASDAQ:AKBA) shareholder returns have been respectable, earning 91% in 1 year - Simply Wall St

Oct 23, 2024

Oct 22, 2024

Akebia Therapeutics secures dialysis drug contract By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Akebia Therapeutics secures dialysis drug contract - Investing.com

Oct 22, 2024

Oct 22, 2024

Akebia Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow

Oct 22, 2024

Oct 22, 2024

Akebia Therapeutics Signs Commercial Supply Contract with Leading Dialysis Organization to Enable Access to Vafseo® (vadadustat) for Patients on Dialysis - Yahoo Finance

Oct 22, 2024

Oct 17, 2024

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionAKBA - AsiaOne

Oct 17, 2024

Oct 16, 2024

Akebia Therapeutics extends supply agreement with STA Pharmaceutical - Investing.com

Oct 16, 2024

Oct 16, 2024

Akebia Therapeutics extends supply agreement with STA Pharmaceutical By Investing.com - Investing.com UK

Oct 16, 2024

Oct 16, 2024

Akebia Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement - Quantisnow

Oct 16, 2024

Oct 15, 2024

Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024 - StockTitan

Oct 15, 2024

Oct 14, 2024

A new trading data show Akebia Therapeutics Inc. (AKBA) is showing positive returns. - SETE News

Oct 14, 2024

Oct 14, 2024

Akebia Therapeutics Inc.’s latest rating changes from various analysts - Knox Daily

Oct 14, 2024

Oct 12, 2024

Akebia shares maintain Buy rating on CMS Vafseo payment decision By Investing.com - Investing.com Canada

Oct 12, 2024

Oct 12, 2024

Marshall Wace LLP Lowers Stake in Akebia Therapeutics, Inc. (NASDAQ:AKBA) - MarketBeat

Oct 12, 2024

Oct 12, 2024

Akebia shares maintain Buy rating on CMS Vafseo payment decision - Investing.com India

Oct 12, 2024